1.Ma, H., Yang, L., Liang, Y., Liu, F., Hu, J., Zhang, R., Li, Y., Yuan, L., & Feng, F. B.thetaiotaomicron-derived Acetic Acid Modulate Immune Microenvironment and Tumor Growth in Hepatocellular Carcinoma. Gut Microbes, 16(1):2297846.
2.Feng, F., Li, T., Liang, Y., Gao, W., & Yang, L. Structural changes and anti-hepatocellular carcinoma activity of interferon-γ after interaction with sinensetin. International Journal of Biological Macromolecules, 253, 126392.
3.Wang, R., Guo, K., zhang, W., He, Y., Yang, K., Chen, Q., Yang, L., Di, Z., Qiu, J., Lei, P., Gu, Y., Luo, Z., Xu, X., Xu, Z., Feng, X., Li, S., Yu, Z., & Xu, H. (2022). Poly‐γ‐Glutamic Acid Microgel‐Encapsulated Probiotics with Gastric Acid Resistance and Smart Inflammatory Factor Targeted Delivery Performance to Ameliorate Colitis. Advanced Functional Materials, 32(26), 2113034.
4. Yang, L., Gao, Q., Wu, X., Feng, F., & Xu, K. (2018). Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway. J Exp Clin Cancer Res, 37(1), 186.
5.Li, Y., Ma, H., Shi, C., Feng, F., & Yang, L. (2020). Mutant ACTB mRNA 35.’-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a. Cell Signal, 67, 109479.
